Skip to content
DataLookout
Menu

SuperHERONCT07895511

A Study of Skipping Radiation Therapy in People With Breast Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Ipsilateral breast recurrence/IBR rate
Timeframe: 5 years

Arms and interventions

HER2-positive Breast CancerExperimental

Participants have HER2-positive Breast Cancer

Drugs: HER2-targeted therapy, Tamoxifen

Radiation: No Radiation Therapy

Sites

7 sites in 1 country